Related Experiment Videos
Priorities and standards in pharmacogenetic research
Anna C Need1, Arno G Motulsky, David B Goldstein
1Institute for Genome Sciences & Policy, Center for Population Genomics & Pharmacogenetics, Duke University, 103 Research Drive, DUMC Box 3471, Durham, North Carolina 27710, USA.
Nature Genetics
|July 2, 2005
Summary
Pharmacogenetics research, focusing on drug response, must acknowledge the complex interplay of multiple genes and environmental factors. Future studies need standardized approaches to realize pharmacogenetics
Area of Science:
- Pharmacogenomics and Precision Medicine
Background:
- Pharmacogenetics aims to tailor drug therapy based on individual genetic makeup.
- Current research is inspired by a few genetic polymorphisms with significant drug response effects.
- Success in Mendelian disease genetics contrasts with challenges in complex disease genetics.
Purpose of the Study:
- To address the complexity of drug response influenced by multiple genes and environmental factors.
- To propose priorities and standards for future pharmacogenetic research.
- To ensure pharmacogenetics delivers on its potential in both research and clinical practice.
Main Methods:
- Systematic investigation of genetic and environmental influences on drug response.
- Development of standardized methodologies for pharmacogenetic research.
- Integration of complex genetic and environmental data in drug response studies.
Main Results:
- Acknowledged limited success in identifying single gene effects for complex traits.
- Recognized that most drug responses are likely multifactorial.
- Highlighted the need for a paradigm shift in pharmacogenetic research approaches.
Conclusions:
- Pharmacogenetics must embrace complexity, moving beyond simple genetic associations.
- Standardized research priorities and applications are crucial for clinical translation.
- Future pharmacogenetic endeavors require a holistic approach considering gene-gene and gene-environment interactions.